Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company. It specializes in manufacturing powder, lyophilized, and liquid products.
Aspiro Pharma Limited, is an unlisted public company incorporated on 05 February, 2014. It is classified as a public limited company and is located in , Telangana. It's authorized share capital is INR 1,415.10 cr and the total paid-up capital is INR 404.15 cr.
Read more
** All rupee values in INR crores. Based on March 2022 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Krishnaveni Kura | 07033330 | 8 years |
| Additional Director | Chandra Sekhar Tumuluru | 07212178 | 5 years |
| Director | Bandi Vamsikrishna
Shareholder
|
01014619 | 12 years |
| Director | Sudhakar Reddy Avuthu | 07766398 | 3 years |
| Director | Reddy Narsimha | 07850148 | 1 years |
| Director | Ramaseshappa Siva Prasad Panchangam | 09447160 | 2 years |
| Director | Mahesh Ramappa Kamalamma Hassan | 08099535 | 2 years |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
RBL Bank Limited
No. of Loans: 1
Total Amount : 105.0 cr
Bajaj Finance Limited
No. of Loans: 1
Total Amount : 100.0 cr
Mahindra and Mahindra Financial Services Limited
No. of Loans: 7
Total Amount : 1.0 cr
HDFC Bank Limited
No. of Loans: 4
Total Amount : 0.7 cr
Union Bank of India
No. of Loans: 2
Total Amount : 0.2 cr
Read more
The incorporation date of ASPIRO PHARMA LIMITED is 05 February, 2014
The authorized share capital of ASPIRO PHARMA LIMITED is INR ₹ 1,415.1 Cr.
The paid-up capital of ASPIRO PHARMA LIMITED is INR ₹ 404.1 Cr.
The registered address of ASPIRO PHARMA LIMITED is Plot No. 23, Survey No.321, Biotech Park Phase-III, Karkapatla Villa, ge, Medak, Markook, Telangana, India, 502281 - 502281
The CIN number of ASPIRO PHARMA LIMITED is U24100TG2014PLC092771.